Search for Clinical Trial Results

Explore a wide range of ongoing clinical trials and research studies. Stay updated on the latest healthcare advancements and medical breakthroughs. Learn how you can participate in medical research to contribute to scientific progress

Acute Myelomonocytic Leukemia - 190 Studies Found

Status Study
Completed Study Name: Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia
Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leuk
Date: 2014-05-20
Interventions: Drug: choline magnesium trisalicylate
Terminated Study Name: AML Therapy With Irradiated Allogeneic Cells
Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leuk
Date: 2014-04-02
Interventions: Drug: fludarabine phosphate Gi
Recruiting Study Name: Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Adult
Date: 2014-03-11
Interventions: Drug: clofarabine Given IV
Recruiting Study Name: Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Adult
Date: 2014-02-24
Interventions: Drug: eltrombopag olamine Given PO Other Names:
Active, not recruiting Study Name: MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition: Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia
Date: 2014-01-28
Interventions: Drug: MEK inhibitor MEK162 Giv
Active, not recruiting Study Name: Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant
Condition: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Adult Acute Megakaryob
Date: 2014-01-15
Interventions: Drug: Lenalidomide Given PO
Terminated Study Name: Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Adult
Date: 2014-01-06
Interventions: Drug: cytarabine Given SC
Terminated Study Name: Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leuk
Date: 2013-11-25
Interventions: Drug: ixazomib Given PO Other Names:
Active, not recruiting Study Name: CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Condition: Adult Acute Erythroid Leukemia (M6) Adult Acute Megakaryoblastic Leukemia (M7)
Date: 2013-11-25
Interventions: Drug: liposomal cytarabine-daunorubicin CPX-351
Active, not recruiting Study Name: Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leuk
Date: 2013-07-17
Interventions: Drug: lenalidomide Given PO
Page 1 of 19
Next >>>